Offor Callistus
June 22, 2025
The recent approval of Yeztugo, a twice-yearly injectable medication for Human Immunodeficiency Virus (HIV) prevention, has sparked mixed reactions from experts. While hailing the breakthrough as a significant advancement in HIV prevention, they warn that the high cost could limit access to millions of vulnerable people worldwide. “This is...

